NASDAQ:SNOA Sonoma Pharmaceuticals (SNOA) News Today $1.40 +0.43 (+44.33%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$1.16▼$1.5250-Day Range$0.92▼$1.4052-Week Range$0.76▼$4.19Volume28.78 million shsAverage Volume33,075 shsMarket Capitalization$6.51 millionP/E RatioN/ADividend YieldN/APrice TargetN/A HeadlinesProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get Sonoma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNOA and its competitors with MarketBeat's FREE daily newsletter. Email Address SNOA Media Mentions By Week SNOA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNOA News Sentiment▼1.320.78▲Average Medical News Sentiment SNOA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNOA Articles This Week▼41▲SNOA Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSonoma Pharmaceuticals Shares Soar 44% After Introducing New Productfinance.yahoo.com - June 9 at 8:57 PMSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Unionfinanznachrichten.de - June 8 at 7:42 PMSonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Unionfinance.yahoo.com - June 8 at 7:42 PMWilliams-Sonoma Could Be Headed for More Troublethestreet.com - May 21 at 10:35 AM8-K: Sonoma Pharmaceuticals, Inc.marketwatch.com - May 11 at 10:59 PMSonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Short Interest Down 25.1% in Aprilamericanbankingnews.com - April 27 at 6:42 AMBenign Growth For Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Underpins Its Share Pricefinance.yahoo.com - April 19 at 5:05 PMGetting Around Sonomatravel.usnews.com - April 14 at 10:11 PMTrack Covid-19 in Sonoma County, Californianytimes.com - April 12 at 1:49 PMSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Carefinanznachrichten.de - April 11 at 10:18 AMSonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Carefinance.yahoo.com - April 11 at 10:18 AMSonoma Plazatravel.usnews.com - April 4 at 2:12 PMSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphiafinanznachrichten.de - March 28 at 7:18 PMSonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphiafinance.yahoo.com - March 28 at 7:18 PMRegeneron to pay Sonoma $75M upfront in pact to develop autoimmune disease drugsseekingalpha.com - March 28 at 9:17 AMSonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectantfinance.yahoo.com - March 2 at 4:01 PMSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Resultsfinanznachrichten.de - February 14 at 7:15 PMSonoma Pharmaceuticals Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - February 14 at 7:15 PMSonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Koreafinance.yahoo.com - January 31 at 8:49 AMSonoma Pharma Shares Rise 82% After Pricing Agreement for Microcyn Rx Productsmarketwatch.com - January 25 at 5:44 PMThese Four Companies Are Attracting Investors Following Recent Newsbenzinga.com - January 25 at 5:44 PMSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn Rx Productsfinanznachrichten.de - January 25 at 12:42 PMWhy Is Sonoma Pharmaceuticals (SNOA) Up 70% Today?investorplace.com - January 25 at 11:07 AMSonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Productsfinance.yahoo.com - January 25 at 7:41 AMSonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spasfinance.yahoo.com - January 4 at 8:57 AMSonoma Pharmaceuticals Second Quarter 2023 Earnings: US$0.33 loss per share (vs US$0.043 loss in 2Q 2022)finance.yahoo.com - November 17 at 10:34 AMSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Resultsfinanznachrichten.de - November 15 at 12:26 AMSonoma Pharmaceuticals Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - November 15 at 12:26 AMSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United Statesfinanznachrichten.de - October 27 at 9:01 PMSonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United Statesfinance.yahoo.com - October 27 at 9:01 PMSonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germanyfinance.yahoo.com - October 6 at 6:30 PMSonoma Pharmaceuticals GAAP EPS of -$0.29, revenue of $3.99Mseekingalpha.com - August 13 at 11:05 PMSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports First Quarter 2023 Financial Resultsfinanznachrichten.de - August 11 at 8:50 PMSonoma Pharmaceuticals Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - August 11 at 8:50 PMSonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products Exclusively for Veterinarian Use and Announces Partnership with DV Medical Supplyfinance.yahoo.com - August 2 at 7:01 PMSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Resultsfinanznachrichten.de - July 13 at 6:58 PMSonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Resultsfinance.yahoo.com - July 13 at 6:58 PMSonoma gains on new U.S. EPA designation for disinfectantseekingalpha.com - June 1 at 2:26 PMSonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19finance.yahoo.com - June 1 at 7:29 AMSonoma, XORTX top healthcare gainers; Spero, Semler Scientific lead losers' packseekingalpha.com - May 4 at 10:00 PMWhy Is Sonoma Pharmaceuticals (SNOA) Stock Up 30% Today?investorplace.com - May 3 at 2:02 PMHere's How PayPal Helped Trigger EU Antitrust Allegations Against Appleuk.investing.com - May 3 at 12:47 PMThinking about buying stock in Sonoma Pharmaceuticals, Chegg, SOS, Redbox Entertainment, or Better Therapeutics?morningstar.com - May 3 at 12:47 PMSonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.finance.yahoo.com - May 3 at 7:46 AMSonoma stock soars 21% on EPA approval of Nanocyn as hospital-grade disinfectantseekingalpha.com - May 3 at 7:46 AMSonoma Pharma Launches New Urinary Tract Infection Product In New Zealand, Australia, South Africafinance.yahoo.com - March 30 at 4:31 PMThe Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdictmsn.com - March 30 at 8:38 AMSonoma Pharma Unveils Microdox In New Zealand, Australia And South Africa - Quick Factsnasdaq.com - March 30 at 8:38 AMSonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africafinance.yahoo.com - March 30 at 8:38 AMSonoma Pharmaceuticals GAAP EPS of -$0.31, revenue of $2.9Mseekingalpha.com - February 11 at 9:08 PM Get Sonoma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNOA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Timber Pharmaceuticals News Today Lexaria Bioscience News Today Kiora Pharmaceuticals News Today Clearmind Medicine News Today Neptune Wellness Solutions News Today InMed Pharmaceuticals News Today Qualigen Therapeutics News Today Aditxt News Today 180 Life Sciences News Today Aptinyx News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:SNOA) was last updated on 6/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.